Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Testing the Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction

NCT04523168 is registered in ClinicalTrials.gov with Amir Lerman as lead sponsor.

NCT NCT04523168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04523168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Testing the Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction
Lead sponsor
Amir Lerman
Phase
Not applicable
Overall status
Completed
Start date
June 28, 2021
Completion date
July 28, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary microvascular dysfunction